Viseven at Reuters Pharma EU
Viseven
MAY 24, 2023
As for artificial intelligence itself, of course, Reuters Pharma could not go without lively discussion of chatGPT and the possibility of its integration in healthcare applications. Individual value is what drives commercial models of these companies and ensures their long-term success.
Let's personalize your content